Amyris

About:

Amyris is a biotech company that creates chemical products using advanced fermentation processes derived from sugarcane.

Website: http://amyris.com

Twitter/X: Amyris

Top Investors: Temasek Holdings, Khosla Ventures, TotalEnergies, Kleiner Perkins, National Institutes of Health

Description:

Amyris Biotechnologies creates renewable products that focus on fuels and chemicals that provide no-compromise sustainable alternatives to a broad range of petroleum-sourced products. It uses an industrial synthetic biology platform that applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. Its technology creates products that support biopharmaceutical drug discovery and production, from cosmetic emollients and fragrances to fuels, solvents, lubricants, and nutraceuticals.

Total Funding Amount:

$1.88B

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Emeryville, California, United States

Founded Date:

2003-01-01

Founders:

Jack Newman, Jay Keasling, Kinkead Reiling, Neil Renninger, Vince Martin

Number of Employees:

501-1000

Last Funding Date:

2024-10-03

IPO Status:

Public

© 2025 bioDAO.ai